National University of Singapore
nus.edu.sgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
202
Active
52
Phase 3
6
Total enrollment
126,056
Pipeline matrix
Showing 15 of 15 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Colistin/Polymyxin B + Sulbactam | — | — | — | — | — | 1 | |
| Colistin/Polymyxin B + Tigecycline/Eravacycline | — | — | — | — | — | 1 | |
| Colistin/Polymyxin B + Meropenem | — | — | — | — | — | 1 | |
| Ceftazidime-avibactam + Sulbactam | — | — | — | — | — | 1 | |
| Ceftazidime-avibactam + Fosfomycin | — | — | — | — | — | 1 | |
| Ceftazidime-avibactam | — | — | — | — | — | 1 | |
| Ceftazidime-avibactam + Aztreonam | — | — | — | — | — | 1 | |
| Ceftazidime-avibactam + Colistin/Polymyxin B | — | — | — | — | — | 1 | |
| High-dose meropenem | — | — | — | — | — | 1 | |
| Meropenem + Fosfomycin | — | — | — | — | — | 1 | |
| Meropenem-vaborbactam | — | — | — | — | — | 1 | |
| Cefiderocol | — | — | — | — | — | 1 | |
| Ceftolozane-tazobactam | — | — | — | — | — | 1 | |
| Ceftolozane-tazobactam + Meropenem | — | — | — | — | — | 1 | |
| Dulaglutide | — | — | — | — | — | 1 |
Next readouts
- 2028-12-31
- 2030-12-01
Top conditions
- Anxiety12
- Sleep11
- Aging10
- Stress10
- Obstructive Sleep Apnea7
- Breast Cancer7
- Depression6
- Stroke5
Frequently asked questions about National University of Singapore
- How many clinical trials does National University of Singapore have on ClinicalTrials.gov?
- National University of Singapore is listed as the lead sponsor on 202 clinical trials in ClinicalTrials.gov, 52 of which are currently active (recruiting, enrolling, or ongoing).
- How many of National University of Singapore's trials are in Phase 3?
- 6 of National University of Singapore's trials are in Phase 3, spread across 15 active drug programs.
- What therapeutic areas does National University of Singapore focus on?
- National University of Singapore's most-studied conditions on ClinicalTrials.gov are Anxiety, Sleep, Aging, Stress, Obstructive Sleep Apnea.
- When are National University of Singapore's next clinical trial readouts?
- National University of Singapore has 2 upcoming primary-completion readouts tracked here; the soonest is “Optimising TREATment for Severe Gram-Negative Bacterial Infections”, expected around 2028-12-31.